1. Home
  2. NTRA vs CVE Comparison

NTRA vs CVE Comparison

Compare NTRA & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$400.92

Market Cap

47.4B

Sector

Health Care

ML Signal

N/A

Logo Cenovus Energy Inc

CVE

Cenovus Energy Inc

N/A

Current Price

$31.37

Market Cap

48.0B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
CVE
Founded
2003
2009
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
47.4B
48.0B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
NTRA
CVE
Price
$400.92
$31.37
Analyst Decision
Strong Buy
Buy
Analyst Count
23
16
Target Price
★ $383.66
$36.48
AVG Volume (30 Days)
1.7M
★ 7.1M
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
★ 1.93%
EPS Growth
★ 0.65
N/A
EPS
N/A
★ N/A
Revenue
★ $210,939,000.00
N/A
Revenue This Year
$26.17
$25.77
Revenue Next Year
$20.65
N/A
P/E Ratio
★ N/A
$18.07
Revenue Growth
N/A
★ N/A
52 Week Low
$169.50
$15.63
52 Week High
$437.41
$34.16

Technical Indicators

Market Signals
Indicator
NTRA
CVE
Relative Strength Index (RSI) 61.52 49.12
Support Level $187.64 $30.25
Resistance Level N/A $32.29
Average True Range (ATR) 17.33 0.83
MACD -3.35 -0.08
Stochastic Oscillator 50.04 51.64

Price Performance

Historical Comparison
NTRA
CVE

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CVE Cenovus Energy Inc

Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.

Share on Social Networks: